Search results
Results from the WOW.Com Content Network
The toxin aflatoxin from certain Aspergillus species of fungi is a carcinogen and aids carcinogenesis of hepatocellular cancer by building up in the liver. The combined high prevalence of rates of aflatoxin and hepatitis B in settings such as China and West Africa has led to relatively high rates of hepatocellular carcinoma in these regions ...
Most cases are metastases from other tumors, frequently of the GI tract (like colon cancer, carcinoid tumors mainly of the appendix, etc.), but also from breast cancer, ovarian cancer, lung cancer, renal cancer, prostate cancer, etc. The most frequent, malignant, primary liver cancer is hepatocellular carcinoma. [13]
The most frequent liver cancer, accounting for approximately 75% of all primary liver cancers, is hepatocellular carcinoma (HCC). [15] HCC is a cancer formed by liver cells, known as hepatocytes, that become malignant. In terms of cancer deaths, worldwide HCC is considered the 3rd most common cause of cancer mortalities. [16]
People get liver cancer (also called hepatocellular carcinoma, HCC or hepatoma) typically from a prolonged Hepatitis B or C infection or as a result of cirrhosis from chronic alcoholism. Liver cancer may bring about yellowing of the skin and eyes ( jaundice ), itching ( pruritus ), or cause a buildup of fluid in the abdomen ( ascites ).
The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer (hepatocellular carcinoma, abbreviated HCC) and lymphomas in humans. [1] [2] [3] An oncovirus or oncogenic virus is a virus that can cause cancer. [4]
Hepatocellular carcinoma; Causes. The list of conditions associated with chronic liver disease is extensive and can be categorised in the following way: [3]
Transitional cell carcinoma, a type of cancer most commonly seen in a dog's bladder, may respond to ivermectin in the same way as human renal cell carcinoma. Unfortunately, there is not yet any ...
The chimeric antigen receptor (CAR) T cell immunotherapies based on GC33, [31] hYP7 [32] [33] and HN3 [34] are being reported at various stages for treating liver cancer. In mice with xenograft or orthoptic liver tumors, CAR (hYP7) T cells can eliminate GPC3-positive cancer cells, by inducing perforin- and granzyme-mediated cell death and ...